Merck Tbk. vs Lancartama Sejati Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Lancartama Sejati Tbk. trades at Rp171 (market cap 218.4B, 7.92M 24h volume). The key difference: Merck Tbk. is far larger — about 7.8× Lancartama Sejati Tbk.'s market cap, and Lancartama Sejati Tbk. is more actively traded (7.92M versus 37.6K). Which is the better fit depends on your goals.
| MERK | TAMA | |
|---|---|---|
Market Cap | 1.7T | 218.4B |
Volume | 37.6K | 7.92M |
Lot | 376 | 79.17K |
Turnover | 144.47M | 1.36B |
Average Price | 3,842.23 | 172.22 |
Value | 144.47M | 1.36B |
Indicative Equilibrium Price | 3,840 | 171 |
Indicative Equilibrium Volume | 7 | 814 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Lancartama Sejati Tbk (the Company) was established based on notary deed No. 12 dated June 01, 1990 of Sugiri Kadarisman, SH., notary in Jakarta.
Read more on TAMA →